BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32785222)

  • 1. The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome.
    Kuang H; Duan Y; Li D; Xu Y; Ai W; Li W; Wang Y; Liu S; Li M; Liu X; Shao M
    PLoS One; 2020; 15(8):e0235404. PubMed ID: 32785222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
    Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway.
    Liu M; Zhu H; Zhu Y; Hu X
    J Ethnopharmacol; 2021 Apr; 270():113821. PubMed ID: 33460753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of antimüllerian hormone in women with polycystic ovary syndrome undergoing assisted reproduction: effect of insulin.
    Liu XY; Yang YJ; Tang CL; Wang K; Chen JJ; Teng XM; Ruan YC; Yang JZ
    Fertil Steril; 2019 Jan; 111(1):157-167. PubMed ID: 30477916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
    Li Y; Tan JQ; Mai ZY; Yang DZ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
    [No Abstract]   [Full Text] [Related]  

  • 6. Defective insulin signaling and the protective effects of dimethyldiguanide during follicular development in the ovaries of polycystic ovary syndrome.
    Wang F; Wang S; Zhang Z; Lin Q; Liu Y; Xiao Y; Xiao K; Wang Z
    Mol Med Rep; 2017 Dec; 16(6):8164-8170. PubMed ID: 28990055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into mechanisms of berberine in alleviating reproductive disorders of polycystic ovary syndrome: Anti-inflammatory properties.
    Xia Q; Wang W; Liu Z; Xiao J; Qiao C; Zhao Y; Li B; Liu Y; Peng Y; Yang X; Shi J; Gao X; Wang D
    Eur J Pharmacol; 2023 Jan; 939():175433. PubMed ID: 36535493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
    Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
    J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S; Ruan J; Huang W; Tan J; Zhang X; Feng X; Liu D; Fu J; Zhou L; Zhou M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influencing of serum inflammatory factors on IVF/ICSI outcomes among PCOS patients with different BMI.
    He Y; Li R; Yin J; Yang Z; Wang Y; Chen L; Yang S; Qiao J
    Front Endocrinol (Lausanne); 2023; 14():1204623. PubMed ID: 37693353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. At the crossroads of fertility and metabolism: the importance of AMPK-dependent signaling in female infertility associated with hyperandrogenism.
    Froment P; Plotton I; Giulivi C; Fabre S; Khoueiry R; Mourad NI; Horman S; Ramé C; Rouillon C; Grandhaye J; Bigot Y; Chevaleyre C; Le Guevel R; Mallegol P; Andriantsitohaina R; Guerif F; Tamburini J; Viollet B; Foretz M; Dupont J
    Hum Reprod; 2022 May; 37(6):1207-1228. PubMed ID: 35459945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive value of anti-Mullerian hormone levels in serum and follicle fluid for IVF-ET outcomes in patients with polycystic ovarian syndrome].
    Chen X; Yin M; Ye D; He Y; Chen S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):546-9. PubMed ID: 23644117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Shen invigorating and Chong-channel regulating method on anti-Müllerian hormone and oocyte quality in polycystic ovarian syndrome patients].
    Lian F; Zhao S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jan; 32(1):9-12. PubMed ID: 22500381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
    Zheng MX; Li Y; Hu R; Wang FM; Zhang XM; Guan B
    J Assist Reprod Genet; 2016 Feb; 33(2):199-205. PubMed ID: 26732661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of Polycystic Ovary Syndrome (PCOS).
    Zhong X; Jin F; Huang C; Du M; Gao M; Wei X
    Technol Health Care; 2021; 29(S1):11-25. PubMed ID: 33682741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
    Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.